{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:02:43Z","timestamp":1785294163416,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jchromb.2023.123685","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:55:59Z","timestamp":1680011759000},"page":"123685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS\/MS is a robust assay for beta-lactam therapeutic drug monitoring"],"prefix":"10.1016","volume":"1221","author":[{"given":"Maeva","family":"Palayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Chaussenery-Lorentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Boubekeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Maubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bourgogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123685_b0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis Occurrence in Acutely Ill Patients Investigators, Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med."},{"key":"10.1016\/j.jchromb.2023.123685_b0010","unstructured":"Saint Maurice, Surveillance de la consommation des antibiotiques. R\u00e9seau ATB-Raisin, France. R\u00e9sultats 2017, 134 pages, (2017). https:\/\/www.santepubliquefrance.fr\/."},{"key":"10.1016\/j.jchromb.2023.123685_b0015","first-page":"3178","article-title":"Therapeutic drug monitoring of the \u03b2-lactam antibiotics: what is the evidence and which patients should we be using it for?","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jchromb.2023.123685_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.CCM.0000050298.59549.4A","article-title":"Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome","volume":"31","author":"Leone","year":"2003","journal-title":"Crit Care Med."},{"key":"10.1016\/j.jchromb.2023.123685_b0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest."},{"key":"10.1016\/j.jchromb.2023.123685_b0030","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med."},{"key":"10.1016\/j.jchromb.2023.123685_b0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s00134-014-3403-8","article-title":"Risk factors for target non-attainment during empirical treatment with \u03b2-lactam antibiotics in critically ill patients","volume":"40","author":"De Waele","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jchromb.2023.123685_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mas.10050","article-title":"Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry","volume":"22","author":"Hopfgartner","year":"2003","journal-title":"Mass Spectrom Rev."},{"key":"10.1016\/j.jchromb.2023.123685_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00216-021-03583-2","article-title":"Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine?","volume":"414","author":"Bravo-Veyrat","year":"2022","journal-title":"Anal Bioanal Chem."},{"key":"10.1016\/j.jchromb.2023.123685_b0050","doi-asserted-by":"crossref","first-page":"e5347","DOI":"10.1002\/bmc.5347","article-title":"Cutting-edge LC\u2013MS\/MS applications in clinical mass spectrometry: Focusing on analysis of drugs and metabolites","volume":"36","author":"Maekawa","year":"2022","journal-title":"Biomedical Chromatography."},{"key":"10.1016\/j.jchromb.2023.123685_b0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC-MS\/MS became routine in clinical diagnostics","volume":"82","author":"Seger","year":"2020","journal-title":"Clin Biochem."},{"key":"10.1016\/j.jchromb.2023.123685_b0060","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.3390\/molecules25174026","article-title":"Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM)","volume":"25","author":"Tuzimski","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.jchromb.2023.123685_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122160","article-title":"Validation and clinical application of a multiplex high performance liquid chromatography \u2013 tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections","volume":"1157","author":"Decosterd","year":"2020","journal-title":"Journal of Chromatography B."},{"key":"10.1016\/j.jchromb.2023.123685_b0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpba.2019.03.004","article-title":"UPLC\/MS\/MS assay for the simultaneous determination of seven antibiotics in human serum\u2013Application to pediatric studies","volume":"174","author":"Magr\u00e9ault","year":"2019","journal-title":"Journal of Pharmaceutical and Biomedical Analysis."},{"key":"10.1016\/j.jchromb.2023.123685_b0075","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/AAC.00176-16","article-title":"Simultaneous Determination of Eight \u03b2-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection","volume":"60","author":"Legrand","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jchromb.2023.123685_b0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2014.04.029","article-title":"Simultaneous determination of seven \u03b2-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies","volume":"960","author":"Sime","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0085","series-title":"Human anatomy & physiology","author":"Solomon","year":"1990"},{"key":"10.1016\/j.jchromb.2023.123685_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-2787(1999)18:3\/4<187::AID-MAS2>3.0.CO;2-K","article-title":"LC\/MS applications in drug development","volume":"18","author":"Lee","year":"1999","journal-title":"Mass Spectrom Rev."},{"key":"10.1016\/j.jchromb.2023.123685_b0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography\u2013tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"Journal of Chromatography B."},{"key":"10.1016\/j.jchromb.2023.123685_b0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpba.2014.09.030","article-title":"Generic on-line solid phase extraction sample preparation strategies for the analysis of drugs in biological matrices by LC-MS\/MS","volume":"102","author":"Bourgogne","year":"2015","journal-title":"J Pharm Biomed Anal."},{"key":"10.1016\/j.jchromb.2023.123685_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1096-9888(199701)32:1<23::AID-JMS449>3.0.CO;2-P","article-title":"Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44\u20133888 and its pro-drug and precursor metabolite in plasma","volume":"32","author":"Zell","year":"1997","journal-title":"J Mass Spectrom."},{"key":"10.1016\/j.jchromb.2023.123685_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchromb.2005.03.007","article-title":"Determination of talinolol in human plasma using automated on-line solid phase extraction combined with atmospheric pressure chemical ionization tandem mass spectrometry","volume":"820","author":"Bourgogne","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0115","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.4155\/bio.13.258","article-title":"Rugged and accurate quantitation of colchicine in human plasma to support colchicine poisoning monitoring by using turbulent-flow LC-MS\/MS analysis","volume":"5","author":"Bourgogne","year":"2013","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2023.123685_b0120","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinchem\/33.4.606","article-title":"Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin","volume":"33","author":"Christenson","year":"1987","journal-title":"Clinical Chemistry."},{"key":"10.1016\/j.jchromb.2023.123685_b0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2017.04.027","article-title":"A reference measurement procedure for amino acids in blood using isotope dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"1055\u20131056","author":"Kim","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jchromb.2007.01.002","article-title":"Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids","volume":"852","author":"Frank","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/15321819.2015.1006330","article-title":"5-sulfosalicylic Acid Dihydrate-Based Pretreatment for the Modification of Enzyme-Linked Immunoassay of Fluoroquinolones in Fishery Products","volume":"36","author":"Cui","year":"2015","journal-title":"Journal of Immunoassay and Immunochemistry."},{"key":"10.1016\/j.jchromb.2023.123685_b0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jat\/16.5.340","article-title":"Whole Blood Deproteinization for Drug Screening Using Automatic Pipettors","volume":"16","author":"Collins","year":"1992","journal-title":"Journal of Analytical Toxicology."},{"key":"10.1016\/j.jchromb.2023.123685_b0155","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bmc.482","article-title":"Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC","volume":"19","author":"Arzuaga","year":"2005","journal-title":"Biomed Chromatogr."},{"key":"10.1016\/j.jchromb.2023.123685_b0160","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jchromb.2023.123685_b0165","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/bmc.597","article-title":"High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma","volume":"20","author":"Boak","year":"2006","journal-title":"Biomed Chromatogr."},{"key":"10.1016\/j.jchromb.2023.123685_b0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpba.2012.04.010","article-title":"Short-term stability studies of ampicillin and cephalexin in aqueous solution and human plasma: Application of least squares method in Arrhenius equation","volume":"73","author":"do Nascimento","year":"2013","journal-title":"J Pharm Biomed Anal."},{"key":"10.1016\/j.jchromb.2023.123685_b0175","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jpba.2005.05.027","article-title":"Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC","volume":"39","author":"Isla","year":"2005","journal-title":"J Pharm Biomed Anal."},{"key":"10.1016\/j.jchromb.2023.123685_b0180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/FTD.0000000000000650","article-title":"Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry","volume":"41","author":"Mortensen","year":"2019","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123685_b0185","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2116\/analsci.32.1269","article-title":"Rapid and Simultaneous Quantitation of Amoxicillin and Clavulanic Acid in Human Plasma and Urine by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study","volume":"32","author":"Fan","year":"2016","journal-title":"Anal Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/bmc.3014","article-title":"Pharmacokinetic study of amoxicillin in human plasma by solid-phase microextraction followed by high-performance liquid chromatography-triple quadrupole mass spectrometry","volume":"28","author":"Szultka","year":"2014","journal-title":"Biomed Chromatogr."},{"key":"10.1016\/j.jchromb.2023.123685_b0195","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/jssc.200600081","article-title":"Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids","volume":"29","author":"Samanidou","year":"2006","journal-title":"J Sep Sci."},{"key":"10.1016\/j.jchromb.2023.123685_b0200","first-page":"679","volume":"44","author":"Vassault","year":"1986","journal-title":"French Society of Clinical Biology. Commission for Validation of Methods, Ann Biol Clin (Paris)."},{"key":"10.1016\/j.jchromb.2023.123685_b0205","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1044-0305(00)00163-X","article-title":"Mechanistic investigation of ionization suppression in electrospray ionization","volume":"11","author":"King","year":"2000","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2023.123685_b0210","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"10.1016\/j.jchromb.2023.123685_b0215","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1039\/D1AN01047F","article-title":"Overview, consequences, and strategies for overcoming matrix effects in LC-MS analysis: a critical review","volume":"146","author":"Nasiri","year":"2021","journal-title":"Analyst."},{"key":"10.1016\/j.jchromb.2023.123685_b0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/food.19850290714","article-title":"Comparative investigations on the precipitation behavior of various protein precipitates in organs and tissues","volume":"29","author":"Kirchner","year":"1985","journal-title":"Nahrung."},{"key":"10.1016\/j.jchromb.2023.123685_b0225","unstructured":"Food and Drug Administration, Bioanalytical Method Guidance, 2018, (n.d.). https:\/\/ www.fda.gov\/media\/70858\/download."},{"key":"10.1016\/j.jchromb.2023.123685_b0230","unstructured":"European Medicines Agency, Bioanalytical Method Guidance, 2011, (n.d.). https:\/\/www.ema.europa.eu\/en\/bioanalytical-method-validation#current-effective-version-section."},{"key":"10.1016\/j.jchromb.2023.123685_b0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2017.05.037","article-title":"Therapeutic drug monitoring of beta-lactam antibiotics \u2013 Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV","volume":"143","author":"Pinder","year":"2017","journal-title":"Journal of Pharmaceutical and Biomedical Analysis."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123685_b0240","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jchromb.2023.123685_b0245","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"J.A. Roberts, S.K. Paul, M. Akova, M. Bassetti, J.J. De Waele, G. Dimopoulos, K.-M. Kaukonen, D. Koulenti, C. Martin, P. Montravers, J. Rello, A. Rhodes, T. Starr, S.C. Wallis, J. Lipman, DALI Study","year":"2014","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jchromb.2023.123685_b0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care."},{"key":"10.1016\/j.jchromb.2023.123685_b0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit Care."},{"key":"10.1016\/j.jchromb.2023.123685_b0260","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jac\/dkz476","article-title":"A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients","volume":"75","author":"Lau","year":"2020","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jchromb.2023.123685_b0265","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.jchromb.2023.123685_b0270","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1093\/jac\/dkaa359","article-title":"Early therapeutic monitoring of \u03b2-lactams and associated therapy outcomes in critically ill patients","volume":"75","author":"Al-Shaer","year":"2020","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jchromb.2023.123685_b0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-022-04050-9","article-title":"Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients","volume":"26","author":"Gatti","year":"2022","journal-title":"Crit Care."},{"key":"10.1016\/j.jchromb.2023.123685_b0145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4155\/bio.13.19","article-title":"The European Bioanalysis Forum community\u2019s evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation","volume":"5","author":"van Amsterdam","year":"2013","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2023.123685_b0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"Journal of Pharmaceutical and Biomedical Analysis."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:10:31Z","timestamp":1761606631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":55,"alternative-id":["S1570023223000958"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123685","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS\/MS is a robust assay for beta-lactam therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123685"}}